Viewing Study NCT03654612


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2025-12-26 @ 10:19 PM
Study NCT ID: NCT03654612
Status: UNKNOWN
Last Update Posted: 2018-10-18
First Post: 2018-08-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies
Sponsor: China International Medical Foundation
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: ChinaIMF-LP02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View